Safety Concerns: Without comprehensive human trials, the FDA cannot assure the safety of BPC-157, including potential side effects, long-term impacts, and appropriate dosages
503A compounded research compound Primary CV mechanism / Upregulation of eNOS and VEGFR2, leading to increased nitric oxide production Arrhythmia data / Attenuated QTc prolongation and ventricular arrhythmias in rat dopamine-toxicity models Blood pressure data / Dose-dependent reduction of systolic BP in hypertensive rat models
Desired Dose mcg = 0.25 mg 5 units to draw U-100 insulin syringe 0.05 mLper dose 5000 mcg/mLconcentration 40doses per vial 5.7 weeksvial lasts Research reference only
One drawback is that such use presents a biological control problem as warm water, with dissolved and suspended solids present, is an excellent medium for growth of microorganisms
Its potential anti-aging benefits and ability to reduce chronic inflammation have also been noted, although these effects require further validation in human studies